Fred M. Schwarzer

Mr. Schwarzer has served as the Chief Executive Officer and a member of the Board of Directors since 2010. Mr. Schwarzer also served as a Managing Partner of Charter Life Sciences, a venture capital firm specializing in life sciences investments, for approximately 15 years. He also served as the Chair of Inviragen, the creators of the DENVax dengue vaccine, from the time of its first venture capital financing until its acquisition by Takeda. He previously served as Chief Executive Officer and then Chair of the Board of Directors of Heska Corporation, a biotechnology company. Mr. Schwarzer received a B.A. in Pre-Legal Studies from the University of Michigan and a J.D. from the University of California, Berkeley, School of Law.